These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15944807)

  • 41. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat.
    Mori S; Sawada T; Okada T; Kubota K
    Surgery; 2008 Apr; 143(4):556-65. PubMed ID: 18374054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardioprotective effect of therapeutic hypothermia at 34°C against ischaemia/reperfusion injury mediated by PI3K and nitric oxide in a rat isolated heart model.
    Mochizuki T; Yu S; Katoh T; Aoki K; Sato S
    Resuscitation; 2012 Feb; 83(2):238-42. PubMed ID: 21875500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
    Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
    Zhang YJ; Bai XJ; Qi ZM; Wang HX
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
    Wang P; Zaragoza C; Holman W
    Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.
    Joyeux-Faure M; Ramond A; Béguin PC; Belaïdi E; Godin-Ribuot D; Ribuot C
    Fundam Clin Pharmacol; 2006 Feb; 20(1):51-6. PubMed ID: 16448394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
    Ikizler M; Erkasap N; Dernek S; Kural T; Kaygisiz Z
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):404-10. PubMed ID: 18065337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.
    Rui T; Feng Q; Lei M; Peng T; Zhang J; Xu M; Abel ED; Xenocostas A; Kvietys PR
    Cardiovasc Res; 2005 Feb; 65(3):719-27. PubMed ID: 15664399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB.
    Xu B; Dong GH; Liu H; Wang YQ; Wu HW; Jing H
    Ann Clin Lab Sci; 2005; 35(2):161-8. PubMed ID: 15943180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin protects the systolic function of neonatal hearts against ischaemia/reperfusion injury.
    Vilarinho KA; de Oliveira PP; Saad MJ; Eghtesady P; Filho LM; Vieira RW; Petrucci O
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):156-62. PubMed ID: 22564802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant human erythropoietin pretreatment attenuates heart ischemia-reperfusion injury in rats by suppressing the systemic inflammatory response.
    Shen Y; Wang Y; Li D; Wang C; Xu B; Dong G; Huang H; Jing H
    Transplant Proc; 2010 Jun; 42(5):1595-7. PubMed ID: 20620481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion.
    Young LH; Ikeda Y; Scalia R; Lefer AM
    J Pharmacol Exp Ther; 2000 Oct; 295(1):37-43. PubMed ID: 10991958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.
    Wynne AM; Mocanu MM; Yellon DM
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):817-22. PubMed ID: 16306807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of erythropoietin on reperfusion arrhythmias in rats].
    Wu JB; Wu PS; Zhang HB; Wang YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1219-22. PubMed ID: 19726366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.